Description

• Application: Novel Hydrolytic Degradable Crosslinked Interpenetrating Polymeric Networks (IPNs): An Efficient Hybrid System to Manage the Controlled Release and Degradation of Misoprostol.: This study explores the use of ammonium peroxodisulfate as an initiator in the synthesis of hydrolytically degradable IPNs for controlled drug release. The innovative approach provides a new avenue for drug delivery systems in pharmaceutical applications (Mehmood et al., 2023). Amikacin-Loaded Chitosan Hydrogel Film Cross-Linked with Folic Acid for Wound Healing Application.: The research utilizes ammonium peroxodisulfate to cross-link chitosan hydrogel films loaded with amikacin, demonstrating enhanced antibacterial properties and potential for wound healing applications (Mehmood et al., 2023). Synthesis and In Vitro Evaluation of Aspartic Acid Based Microgels for Sustained Drug Delivery.: This paper highlights the role of ammonium peroxodisulfate in the synthesis of aspartic acid-based microgels, which exhibit promising results for sustained drug delivery systems (Suhail et al., 2021). Fabrication and In Vitro Evaluation of pH-Sensitive Polymeric Hydrogels as Controlled Release Carriers.: The study investigates the use of ammonium peroxodisulfate in the fabrication of pH-sensitive polymeric hydrogels, offering potential for controlled release applications in pharmaceuticals (Suhail et al., 2021). Extraction of Lithium from Single-Crystalline Lithium Manganese Oxide Nanotubes Using Ammonium Peroxodisulfate.: This research presents a novel method for extracting lithium using ammonium peroxodisulfate, highlighting its significance in the development of advanced materials for energy storage applications (Shi et al., 2020).
• Analysis Note: Assay (iodometric): ≥ 98.0 %Identity: passes testChloride (Cl): ≤ 0.002 %Heavy metals (as Pb): ≤ 0.003 %Fe (Iron): ≤ 0.001 %Mn (Manganese): ≤ 0.0002 %Residue on ignition (as SO₄): ≤ 0.1 %
• Legal Information: EMPLURA is a registered trademark of Merck KGaA, Darmstadt, Germany